Companies Cryptocurrencies
Ionis Pharmaceuticals Inc
Ionis Pharmaceuticals Inc
Exchange: Nasdaq Global Select
IPO Date: 17/05/1991
CEO: Dr. Stanley Crooke
Biotechnology Healthcare 🔗
  • IONS
  • 37.02
  • 5249361920
    market cap
  • -0.5400009
If you bought

shares of Ionis Pharmaceuticals Inc (IONS) on
You would have made
Old Price $12 Current Price $12

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company is headquartered in Carlsbad, California and currently employs 737 full-time employees. The Company, using its drug discovery platform, has developed a pipeline of drugs for patients with unmet medical needs. The firm’s segments include Ionis Core and Akcea Therapeutics. In the Ionis Core segment, the Company is engaged in exploiting a drug discovery platform to generate a pipeline of drugs for the Company and its partners. The Akcea Therapeutics segment includes the operations of the Company’s subsidiary, Akcea Therapeutics, Inc. (Akcea Therapeutics). Akcea Therapeutics is focused on developing and commercializing volanesorsen and other clinical-stage drugs for serious cardiometabolic diseases caused by lipid disorders. The firm is developing volanesorsen to treat two severe and rare, genetically defined diseases, familial chylomicronemia (FCS) and familial partial lipodystrophy (FPL). The firm offers SPINRAZA, a Generation 2.0+ antisense drug.

Address: 2855 Gazelle Ct Carlsbad CALIFORNIA 92010

Stay updated.